These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Substituting for troglitazone (Rezulin). Med Lett Drugs Ther; 2000 Apr; 42(1076):36. PubMed ID: 10803176 [No Abstract] [Full Text] [Related]
3. Pulmonary edema associated with troglitazone therapy. Hirsch IB; Kelly J; Cooper S Arch Intern Med; 1999 Aug 9-23; 159(15):1811. PubMed ID: 10448787 [No Abstract] [Full Text] [Related]
4. Pleuropulmonary disease in a man with diabetes who was treated with troglitazone. Koshida H; Shibata K; Kametani T N Engl J Med; 1998 Nov; 339(19):1400-1. PubMed ID: 9841315 [No Abstract] [Full Text] [Related]
5. Conversion from troglitazone to rosiglitazone. Bell DS; Ovalle F; Shadmany S Endocr Pract; 2001; 7(4):326. PubMed ID: 11497487 [No Abstract] [Full Text] [Related]
6. Hepatic injury due to troglitazone. Malik AH; Prasad P; Saboorian MH; Thiele DL; Malet PF Dig Dis Sci; 2000 Jan; 45(1):210-4. PubMed ID: 10695637 [No Abstract] [Full Text] [Related]
7. Acute rhabdomyolysis associated with troglitazone. Yokoyama M; Izumiya Y; Yoshizawa M; Usuda R Diabetes Care; 2000 Mar; 23(3):421-2. PubMed ID: 10868879 [No Abstract] [Full Text] [Related]
8. Does pioglitazone, like troglitazone, increase serum levels of lipoprotein(a) in diabetic patients? Nagai Y; Abe T; Nomura G Diabetes Care; 2001 Feb; 24(2):408-9. PubMed ID: 11213903 [No Abstract] [Full Text] [Related]
9. Diabetes drug Rezulin: take it, but take precautions. Health News; 1999 May; 5(6):7. PubMed ID: 10546576 [No Abstract] [Full Text] [Related]
10. Severe but reversible hepatitis induced by troglitazone. Schiano T; Dolehide K; Hart J; Baker AL Dig Dis Sci; 2000 May; 45(5):1039-42. PubMed ID: 10795774 [No Abstract] [Full Text] [Related]
12. Fatal hepatotoxicity associated with troglitazone. Vella A; de Groen PC; Dinneen SF Ann Intern Med; 1998 Dec; 129(12):1080. PubMed ID: 9867776 [No Abstract] [Full Text] [Related]
13. A drug interaction between troglitazone and simvastatin. Lin JC; Ito MK Diabetes Care; 1999 Dec; 22(12):2104-6. PubMed ID: 10587866 [No Abstract] [Full Text] [Related]
14. Deterioration of rheumatoid arthritis with troglitazone: a rare and unexpected adverse effect. Sakurai A; Hashizume K Arch Intern Med; 2000 Jan; 160(1):118-9. PubMed ID: 10632316 [No Abstract] [Full Text] [Related]
15. Rezulin to be withdrawn from the market. Diabetes Technol Ther; 2000; 2(2):289. PubMed ID: 11469272 [No Abstract] [Full Text] [Related]
16. FDA reviews troglitazone. Donnelly R Diabetes Obes Metab; 1999 Mar; 1(2):65-6. PubMed ID: 11220513 [No Abstract] [Full Text] [Related]
18. Two cases of severe clinical and histologic hepatotoxicity associated with troglitazone. Gitlin N; Julie NL; Spurr CL; Lim KN; Juarbe HM Ann Intern Med; 1998 Jul; 129(1):36-8. PubMed ID: 9652997 [No Abstract] [Full Text] [Related]
19. Troglitazone-induced fulminant hepatitis: report of a case with autopsy findings. Li H; Heller DS; Leevy CB; Zierer KG; Klein KM J Diabetes Complications; 2000; 14(3):175-7. PubMed ID: 10989325 [TBL] [Abstract][Full Text] [Related]
20. A comparison in a clinical setting of the efficacy and side effects of three thiazolidinediones. King AB Diabetes Care; 2000 Apr; 23(4):557. PubMed ID: 10857952 [No Abstract] [Full Text] [Related] [Next] [New Search]